Wilson Sonsini - ECP

insight detail

Wilson Sonsini Represents New Enterprise Associates (NEA) and Versant Ventures on 858 Therapeutics’ $60 Million Series A Financing

  • 09/21/21
  • Client Highlights
  • Financial Services

ECP Attorneys:

Copyright © 2022 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.